Dr. David M. Aboulafia, MD
- Medicare services, 2024
- 1,715
- Medicare patients, 2024
- 445
- Part D claims, 2024
- 4,581
- Publications
- 58
- Clinical trials
- 11
- Practice address
- 1100 9th Ave, Seattle, WA 98101
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Virginia Mason Medical Center - HOPD
Acute Care Hospital outpatient department · Seattle, Washington
Find Dr. Aboulafia's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David M. Aboulafia is a hematologist and oncologist in Seattle, Washington
Dr. Aboulafia practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.
Dr. Aboulafia's NPI, 1043269392, was assigned on May 6, 2006. Dr. Aboulafia graduated from University of Michigan Medical School in 1983. Dr. Aboulafia holds Washington license MD00027799.
- NPI
- 1043269392NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6406740943
- NPI enumeration date
- May 6, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 69
- Medical school graduation
- 1983
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David M. Aboulafia practices at Virginia Mason Medical Center - HOPD in Seattle, Washington
Dr. Aboulafia's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.
- Virginia Mason Medical Center - HOPD1100 9th Ave, Seattle, WA 98101
Source: Dmand AI Affiliation Data
Dr. David M. Aboulafia is affiliated with 10 sites of care and 3 medical groups
Dr. Aboulafia's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Aboulafia is also affiliated with Virginia Mason Medical Center. The medical group on file is Franciscan Orthopedics - Silverdale. Dmand AI also links Dr. Aboulafia to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 imaging center, each named with a free account. Dr. Aboulafia's employer is on file too: a hospital.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. David M. Aboulafia's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aboulafia practices, 10 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Virginia Mason Medical Center - HOPD | Available with a free account |
| +9 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David M. Aboulafia is one of 348 hematologists and oncologists in Washington
Hematology and oncology is Dr. Aboulafia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Aboulafia is licensed in Washington.
Specialties and state licenses
- Hematology and oncology, WashingtonPrimary
Hematologists and oncologists near Dr. Aboulafia
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David M. Aboulafia billed Medicare for 1,715 services in 2024
CMS data shows 1,715 Medicare services from Dr. Aboulafia across 10 procedure codes in 2024, for 445 Medicare patients. Medicare paid $121,103 for them.
Dr. Aboulafia's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,5772024: 1,28119%
- Surgery
- 2023: 5192024: 41620%
- Lab and pathology
- 2023: 772024: 1877%
Where Dr. Aboulafia's Medicare services took place, 2024
- In an office87251%
- In a facility84349%
Dr. Aboulafia compared with the Washington median for hematologists and oncologists, 2024
- Dr. Aboulafia
- Washington median
- Medicare services
- 1,715vs 5852.9 times
- Medicare patients
- 445vs 1822.4 times
- Part D claims
- 4,066vs 28314.4 times
Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Aboulafia's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Aboulafia?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Aboulafia and other hematologists and oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David M. Aboulafia treated 445 Medicare patients in 2024, average age 75
CMS counts 445 Medicare patients who saw Dr. Aboulafia in 2024. The largest group is 75 to 84, with 184 patients. 61% of them have high blood pressure, and 61% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Aboulafia's median patient age at 73, with 42% women.
Dr. Aboulafia's Medicare patients by age, 2024
Dr. Aboulafia's Medicare patients by sex, 2024
- Women17239%
- Men27361%
Chronic conditions among Dr. Aboulafia's Medicare patients, 2024
- High blood pressure61%
- High cholesterol61%
- Arthritis41%
- Ischemic heart disease26%
- Cancer24%
- Chronic kidney disease24%
- Diabetes23%
- Atrial fibrillation22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Aboulafia's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women42%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. David M. Aboulafia wrote 4,581 Medicare Part D claims in 2024
In 2024, Dr. Aboulafia wrote 4,581 Medicare Part D claims for 297 patients. 63% of them were for generic drugs. CMS names the drug for 4,066 of them, across 107 drugs with 11 or more claims each, at $9,095,416 in total drug cost. In 2023, CMS named 4,475 claims across 116 drugs.
Dr. Aboulafia's Part D claims by kind of drug, 2024
- Generic2,885 claims63%
- Brand-name1,682 claims37%
- Other14 claims0%
Dr. Aboulafia's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Aboulafia's Part D claims, 2024
- Opioids4%186 of 4,581 claims
- Antibiotics1%44 of 4,581 claims
- Antipsychotics, patients 65 and over0%15 of 4,581 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4,4752024: 4,0669%
Drugs named by CMS: 107 in 2024, 116 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. David M. Aboulafia offers telehealth to Medicare patients
Dr. Aboulafia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aboulafia as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David M. Aboulafia has 58 publications on record
Dmand AI links 58 papers to Dr. Aboulafia, published from 2010 to 2025. 2018 was the busiest year, with 6. The most frequent topics are HIV Infections, Acquired Immunodeficiency Syndrome and Anus Neoplasms. Dr. Aboulafia has published most often in Clin Med Insights Blood Disord. Dr. Aboulafia's most frequent co-authors are Prakash Vishnu, MBBS, MD, Ronald Takeshi Mitsuyasu, MD and Joel M. Palefsky, MD.
Dr. Aboulafia's papers by year, 2016 to 2025
Topics Dr. Aboulafia writes about most
- HIV Infections
- Acquired Immunodeficiency Syndrome
- Anus Neoplasms
- Papillomavirus Infections
- Polyethylene Glycols
- Antiretroviral Therapy, Highly Active
- Breast Neoplasms
- Early Detection of Cancer
Dr. Aboulafia's most frequent co-authors
- Prakash Vishnu, MBBS, MD10 shared papers
- Ronald Takeshi Mitsuyasu, MD8 shared papers
- Joel M. Palefsky, MD5 shared papers
Recent publications by Dr. Aboulafia
JCO Oncol Pract
See who Dr. Aboulafia researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Aboulafia works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David M. Aboulafia has worked on 11 clinical trials
Dmand AI links Dr. Aboulafia to 11 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Squamous Intraepithelial Lesions, Anus Neoplasms and Morphological and Microscopic Findings. AIDS Malignancy Consortium sponsors the most, 5. Open Payments lists research payments to Dr. Aboulafia that name 2 trials.
Clinical trials with Dr. Aboulafia by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 3Phase 2: 3 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Aboulafia's trials
- Squamous Intraepithelial Lesions
- Anus Neoplasms
- Morphological and Microscopic Findings
- Anal Canal Carcinoma
- Atypical Hemolytic Uremic Syndrome
Investigators on the most trials with Dr. Aboulafia
- Ronald Takeshi Mitsuyasu, MD7 shared trials
- Paul G. Rubinstein, MD5 shared trials
- Lee Ratner, MD4 shared trials
Recent clinical trials with Dr. Aboulafia
A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons (opens in a new tab)
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas (opens in a new tab)
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma (opens in a new tab)
Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David M. Aboulafia received $47,265 in industry payments from 2016 to 2025
CMS Open Payments shows 78 general payments to Dr. Aboulafia from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Gilead Sciences, Inc. paid the most, $14,926. It also lists 4 research payments totaling $57,685 from 2017 to 2019, naming 2 clinical trials.
General payments to Dr. Aboulafia by program year, 2016 to 2025
General payments to Dr. Aboulafia by kind, 2016 to 2025
- Consulting fees$31,51167%
- Honoraria$6,00013%
- Travel and lodging$4,83710%
- Speaker and faculty fees$3,0006%
- Other$1,9174%
Companies that paid Dr. Aboulafia the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David M. Aboulafia graduated from University of Michigan Medical School
Dr. Aboulafia graduated from University of Michigan Medical School in 1983.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. David M. Aboulafia's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David M. Aboulafia
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David M. Aboulafia's NPI number?
Dr. David M. Aboulafia's NPI number is 1043269392. It was assigned on May 6, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David M. Aboulafia?
Dr. David M. Aboulafia is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. David M. Aboulafia practice?
Dr. Aboulafia practices at 1100 9th Ave, Seattle, WA 98101. Dr. Aboulafia's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dmand AI also links Dr. Aboulafia to 4 hospitals, 3 group practices and clinics, 2 medical groups and 1 imaging center.
What is Dr. David M. Aboulafia's medical license number?
Dr. Aboulafia holds Washington license MD00027799.
Which hospitals is Dr. David M. Aboulafia affiliated with?
Dr. Aboulafia is affiliated with Virginia Mason Medical Center. Dmand AI links Dr. Aboulafia to 4 more hospitals.
What medical group is Dr. David M. Aboulafia part of?
Dr. Aboulafia is linked to Franciscan Orthopedics - Silverdale. Dmand AI links Dr. Aboulafia to 2 more medical groups.
Does Dr. David M. Aboulafia accept Medicare?
Yes. CMS data shows Dr. Aboulafia billed Medicare for 1,715 services in 2024, and Dr. Aboulafia accepts Medicare assignment.
Does Dr. David M. Aboulafia offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Aboulafia as offering telehealth services.
How many Medicare patients does Dr. David M. Aboulafia see?
CMS counts 445 Medicare patients who saw Dr. Aboulafia in 2024, with an average age of 75.
What services does Dr. David M. Aboulafia bill to Medicare?
In 2024, Dr. Aboulafia's most billed Medicare services were office visit, established patient (99214), surgery: heart and blood vessels (36415) and hospital inpatient care (99233).
Show 6 more questionsShow fewer questions
Where did Dr. David M. Aboulafia go to medical school?
Dr. Aboulafia graduated from University of Michigan Medical School in 1983.
What drugs does Dr. David M. Aboulafia prescribe most?
In 2024 Medicare Part D data, Dr. Aboulafia's most prescribed drugs by claims were Juluca, Atorvastatin Calcium and Hydroxyurea.
Has Dr. David M. Aboulafia received payments from drug or device companies?
CMS Open Payments shows $47,265 in general payments to Dr. Aboulafia from 14 companies from 2016 to 2025. The largest total came from Gilead Sciences, Inc.
How long has Dr. David M. Aboulafia been practicing?
Dr. Aboulafia graduated from medical school in 1983, 43 years ago.
Does Dr. David M. Aboulafia do research?
Dmand AI links 58 publications to Dr. Aboulafia, published from 2010 to 2025. Dr. Aboulafia has worked on 11 clinical trials.
Who does Dr. David M. Aboulafia publish with?
Dr. Aboulafia's most frequent co-authors are Prakash Vishnu, MBBS, MD (10 shared papers), Ronald Takeshi Mitsuyasu, MD (8 shared papers) and Joel M. Palefsky, MD (5 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card